Baltimore, MD – According to filings with the U.S. Securities and Exchange Commission, Sonavex is raising $5,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Narrow played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sonavex
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins focused on Empowered Patient Care. The company has developed a portfolio of novel ultrasound solutions to visualize and quantify critical clinical data for improved outcomes and reduced costs in new surgical applications. EchoMark is a bioresorbable and highly echogenic (visible under ultrasound) implant used to mark at-risk blood vessels such that the surgical site can be easily monitored. EchoSure is an automated ultrasound device used by surgeons or nurses for monitoring blood flow in vessels marked by the implanted EchoMark device. The technology provides real-time, visual and quantitative blood flow data on demand, and comes with an app to enable remote monitoring. EchoMark and EchoSure provide clinicians with a non-invasive, clear, and reliable assessment of blood flow in reconstructive, peripheral bypass, AV access, and transplant surgeries.

To learn more about Sonavex, visit http://www.sonavex.com/

Contact:
David Narrow, Chief Executive Officer
443-862-2024
https://www.linkedin.com/in/david-narrow-a4454023/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved